Profound Medical (PRN)
PRN · BiotechSign PipelinePipeline Overview
- Therapeutic Focus
- TULSA-PRO Prostatesrc
Signal Snapshot
3
Clinical Trials (ClinicalTrials.gov aggregate)
0
Catalyst Records
5
Publications on Record
ClinicalTrials.gov aggregate as of 2026-09-28. Source
Recent Publications
- Artificial intelligence in non-small cell lung cancer: transforming diagnosis, treatment, and prognostic evaluation. — Front Med (Lausanne) (2026) PMID 42769889
- Photothermal-driven sequential immunotherapy overcomes resistance to PARP inhibition in Brca1-deficient triple-negative breast cancer. — Acta Pharm Sin B (2026) PMID 42765032
5 total publications tracked — view all on BiotechSign
Get real-time catalyst alerts, analyst signals, dilution risk scores, and full pipeline data for Profound Medical.
Full PRN Data Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.